Peel Hunt Limited Reiterates Halma (HLMAF) Buy Recommendation

Peel Hunt reiterated a Buy on Halma (OTCPK:HLMAF) on Nov. 20, 2025, with the street one‑year average target at $47.30 (range $33.53–$55.99), implying ~63.6% upside from the $28.91 close; analyst optimism contrasts with company projections showing annual revenue of 2,028MM (down 15.9%) and projected non‑GAAP EPS of 0.86. Institutional ownership is mixed: 330 funds report positions (down two owners last quarter) and total shares held fell 2.85% to 57,705K, but average portfolio weight increased 15.8% as major passive and active managers (Vanguard, Fidelity, iShares) modestly raised allocations. The combination of a sizable analyst upside call and deteriorating near‑term revenue highlights a divergence between bullish valuation expectations and near‑term operational pressure, leaving the stock sensitive to upcoming operational or results‑driven catalysts.

Analysis

Peel Hunt reiterated a Buy on Halma (OTCPK:HLMAF) on November 20, 2025; the street one‑year average price target as of November 17 is $47.30, with a range of $33.53–$55.99, implying approximately 63.62% upside from the latest close of $28.91. This analyst optimism establishes a valuation narrative that expects either a recovery in operating performance or a re‑rating by the market.

Reported projections show annual revenue of $2,028MM, a decline of 15.89%, and projected non‑GAAP EPS of 0.86, signalling near‑term operational pressure rather than immediate earnings expansion. The material revenue decline juxtaposed with large price‑target upside highlights a clear disconnect between bullish analyst expectations and current top‑line weakness.

Institutional positioning is mixed: 330 funds report positions (down two owners quarter‑over‑quarter), total institutional shares fell 2.85% to 57,705K, yet average portfolio weight rose 15.83% and major managers (Vanguard, Fidelity, iShares) modestly increased allocations. This suggests underlying support from large passive and active funds but leaves the stock sensitive to upcoming operational releases and guidance; sentiment metrics are moderately positive while near‑term market impact appears limited.

Key Decisions for Investors

• Consider a tactical buy‑on‑weakness approach given the 63.6% analyst‑implied upside, but only after evidence of revenue stabilization or improving guidance appears
• Monitor the next earnings release and management commentary closely and be prepared to trim exposure if revenue decline persists or EPS guidance disappoints
• If holding a material position, employ size discipline or hedges such as protective puts because institutional shares have declined 2.85% and the stock is sentiment‑sensitive
• Track filings from Vanguard, Fidelity and iShares for shifts in passive allocations that could materially influence near‑term support or pressure on the share price